Nine in Ten Eligible Migraine Patients in Japan Have Never Tried CGRP Preventive Antibodies
A nationwide Japanese survey found that roughly 90 percent of people with migraine who met criteria for CGRP monoclonal antibody ...
A nationwide Japanese survey found that roughly 90 percent of people with migraine who met criteria for CGRP monoclonal antibody ...
Researchers propose a testable framework that pairs Traditional Chinese Medicine's preventive-treatment doctrine with digital phenotyping and dual-engine AI analysis for ...
A new editorial argues that progress in pediatric tuberculosis depends less on novel tests than on connecting diagnostics to timely ...
A large Brazilian cohort study of over 31,000 children and adolescents finds that shorter tuberculosis preventive treatment regimens, particularly 3HP, ...
A Swiss real-world registry study found no recurrent ischemic events or new brain lesions among 17 migraine patients with prior ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.